Pliant Therapeutics (PLRX) Long-Term Debt Issuances (2022 - 2024)

Pliant Therapeutics (PLRX) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $1000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to $1000.0 in Q4 2024 year-over-year; TTM through Sep 2025 was $1000.0, a 99.99% decrease, with the full-year FY2024 number at $19.9 million, changed N/A from a year prior.
  • Long-Term Debt Issuances was $1000.0 for Q4 2024 at Pliant Therapeutics, down from $19.9 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $19.9 million in Q1 2024 to a low of -$150000.0 in Q4 2022.